Understanding how AMPK regulates mucosal defense in ear infections
Novel regulation of mucosal innate defense by AMPK in Otitis Media
This study is looking at how a protein called mucin helps protect kids from ear infections, and it aims to find new ways to boost mucin production safely, which could lead to better treatments that don’t use antibiotics.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia State University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11062528 on NIH RePORTER |
What this research studies
This research investigates the role of mucin, a key protein in mucus, in protecting against bacterial infections like otitis media, which is a common ear infection in children. The study aims to uncover the molecular mechanisms that control mucin production, as excessive mucin can lead to hearing loss and other complications. By focusing on the regulation of mucin through AMPK, the research seeks to identify new therapeutic targets that could help manage or prevent these infections without relying on antibiotics. This could lead to innovative treatments that address the growing issue of antibiotic resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are children who frequently experience otitis media or are at high risk for developing this condition.
Not a fit: Patients who do not suffer from otitis media or related mucosal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new non-antibiotic therapies for preventing and treating ear infections in children.
How similar studies have performed: While the regulation of mucin is a well-studied area, the specific focus on AMPK in the context of otitis media is relatively novel and has not been extensively tested.
Where this research is happening
Atlanta, United States
- Georgia State University — Atlanta, United States (Active)
Researchers
- Principal investigator: Li, Jian-Dong — Georgia State University
- Study coordinator: Li, Jian-Dong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.